Osaka, Japan

Ryozo Maeda

This inventor holds 5 USPTO granted patents. Top assignee: Shionogi Company Limited. Active years: 1976-1978.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ryozo Maeda. Retrieved from https://idiyas.com/inventor/ryozo-maeda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1976-1978

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Ryozo Maeda: Innovator in Thiazole Derivatives

Introduction

Ryozo Maeda is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his work on thiazole derivatives. With a total of 5 patents to his name, Maeda's innovations have the potential to impact various therapeutic areas.

Latest Patents

Maeda's latest patents focus on thiazole derivatives that are useful as anti-inflammatory, anti-rheumatic, analgesic, or anti-lipemia agents. These compounds are represented by complex chemical formulas, where A can be oxygen, sulfur, imino, or NR₃, and R₃ can be a variety of alkyl or aralkyl groups. His work also includes thiazole derivatives of benzoic and phenylalkanoic acids, which share similar structural characteristics and therapeutic applications.

Career Highlights

Ryozo Maeda is currently associated with Shionogi & Company Limited, a well-respected pharmaceutical company. His research and development efforts have contributed to the advancement of new therapeutic agents, showcasing his expertise in the field.

Collaborations

Maeda collaborates with various professionals in his field, including his coworker Katsumi Hirose. Their combined efforts aim to push the boundaries of medicinal chemistry and develop innovative solutions for health-related challenges.

Conclusion

Ryozo Maeda's work in thiazole derivatives exemplifies the importance of innovation in the pharmaceutical industry. His contributions not only enhance our understanding of medicinal compounds but also pave the way for future advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…